openPR Logo
Press release

Uveitis treatment Market Report 2023: By Key Players, Trends, Size, Share and Forecast 2023-2029

03-22-2023 02:25 PM CET | Health & Medicine

Press release from: Orion Market Research

Uveitis treatment Market Report 2023: By Key Players, Trends,

The global uveitis treatment market is projected to exhibit a significant growth, at a CAGR of around 6.1%, during the forecast period. The increasing prevalence of uveitis with the rising autoimmune disorders and eye-related disorders has been offering growth to the uveitis treatment market. The growing government initiatives to aware population and provide better healthcare facilities are further creating enormous growth opportunities for the uveitis treatment market in the emerging nations, such as India and China. In addition, the increasing healthcare expenditure and growing medical industry will escalate the market growth during the forecast period. An increasing number of hospitals and ophthalmic clinics in emerging economies are providing immense growth opportunities for the uveitis treatment market.

To learn more about this report request a sample copy @

Such factors have further propelled the need for advanced treatment solutions for uveitis. A new journey can be expected in the uveitis treatment market with the introduction of the novel delivery systems across the globe. This includes the introduction of Iontophoresis for the treatment of anterior uveitis. Iontophoresis refers to the use of an electric current, to propel molecules over the hydrophilic cornea epithelium, which is one of the largest roadblocks to drug penetration in an eye. This expectedly increase the bioavailability of medications, such as steroids, allowing greater reduction in the frequency doses and increase in efficiency, when compared to topical corticosteroids.

Moreover, in May 2018, Clearside Biomedical Inc. introduced novel drug therapy for the treatment of back-of-the-eye diseases. The company announced the attainment for the positive topline results from its new Phase 3 clinical trial of suprachoroidal CLS-TA in patients dealing with macular edema associated with non-infectious uveitis. As per the survey, nearly 47% of patients who were given suprachoroidal CLS-TA for around 12 weeks continuously have gained around 15 letters in best corrected visual acuity ("BCVA"), as measured using the Early Treatment of Diabetic Retinopathy Study ("ETDRS") scale. Moreover, the trial was well tolerated, with no report of any kind of the serious adverse events during the trial.

Intravitreal Sirolimus is another treatment solution available for the uveitis. It is an immunomodulating agent that reduces the number of T-cells and inflammatory cytokines in the patient's body. Oral sirolimus is widely used for the treatment of posterior uveitis; however, due to its certain side effects, the physicians do not recommend. There is an ongoing phase 3 study for the investigation of intravitreal sirolimus for the treatment of non-infectious posterior uveitis treatment. In addition, the intravitreal sirolimus has a lower rate of side effects as compared to intravitreal corticosteroids. Such development in the uveitis treatment solutions will drive the market growth during the forecast period.

Global Uveitis Treatment Market-Segmentation

By Disease Type

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan Uveitis

By Treatment Type

Monoclonal Antibodies
Cycloplegic Agents
Others (Antiviral and Antibiotics)

A full report of Uveitis Treatment Market is available at:

Global Uveitis Treatment Market- Segment by Region

North America

United States


United Kingdom
Rest of Europe


Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

AbbVie Inc.
Aldeyra Therapeutics, Inc.
Alimera Sciences, Inc.
Allergan PLC
Bausch Health Companies Inc.
Cadila Pharmaceuticals Ltd.
Clearside Biomedical, Inc.
EyePoint Pharmaceuticals, Inc.
Mylan NV
Novartis AG
Pfizer Inc.
Prometheus Laboratories Inc.
Santen Pharmaceutical Co., Ltd.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

Media Contact:

Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis treatment Market Report 2023: By Key Players, Trends, Size, Share and Forecast 2023-2029 here

News-ID: 2985456 • Views: 1130

More Releases from Orion Market Research

Gene Editing Market Trends, Segmentation, Growth, Analysis and Forecast 2023-202 …
The global gene editing market is estimated to grow at a significant CAGR of over 14% during the forecast period. The market growth is attributed to the increasing prevalence of genetic disorders, increasing demand for precision medicines, and a significant rise in the R&D expenditure by the industry players. Some of the players operating in the global gene editing industry include GenScript Technologies Corp., Merck KGaA, Integrated DNA Technologies Inc.
Digital PCR and Real-Time PCR Market Trends, Segmentation, Growth, Analysis and …
The digital PCR and real-time PCR market have anticipated to grow at a CAGR of 8.0% during the forecast period attributed to advancements in technology. The Digital Chain Reaction (dPCR) is a method for the quantification of target nucleic acids. The different aspects of PCR assay that includes nanotechnology, microfluidics, and robotics, that enables in the rapid advancement of new procedures. Digital PCR and Real-Time PCR Market reports provides us
CAR T Cell Therapy Market Trends, Segmentation, Growth, Analysis and Forecast 20 …
Global CAR T cell therapy market is estimated to grow at a CAGR of 12.0% during the forecast period. Chimeric antigen receptor (CAR) T-cell therapy treats certain cancers by turning T-lymphocytes or T-cells into more efficient cancer-fighting machines. In the past three years, the number of cancer survivors living in the US increased by more than a million, reaching greater than 18 million as of January 2022, according to the
Bone Morphogenetic Protein (BMP) Market Size, Share, Growth, Analysis and Foreca …
The global bone morphogenetic protein (BMP) market is estimated to grow at a CAGR of nearly 3.0% during the forecast period. Increasing spine injuries are supporting to drive the market growth. Increasing number of road accidents and sports injuries are one of the major causes of spine injuries. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence

All 5 Releases

More Releases for Uveitis

Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &
Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and